SCHEMBL31146876

SCHEMBL31146876

CN(C(=O)C(F)F)c1cc2c(cc1I)OCO2

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
EPHX2 P34913 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
POLB P06746 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995590 0.73 CHRNA7 (0.34) TSHRHSD17B10L3MBTL1NPC1RAB9A
SCHEMBL31146887 0.73 TAAR1 (0.32)
SCHEMBL31146868 0.67 PTGS2 (0.40) TSHRHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL31146889 0.66 NPC1 (0.40) TSHRL3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL31709528 0.64 CYP3A4 (0.44) HSD17B10L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL1742802 0.64 CYP3A4 (0.44) HSD17B10L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL31146867 0.64 CYP3A4 (0.38) SMN1; SMN2ALDH1A1HPGDCYP3A4POLB
SCHEMBL31146882 0.64 DAO (0.35) NPC1RAB9AKMT2A
SCHEMBL14518799 0.62 NPC1 (0.46) GABRA1GABRB2L3MBTL1NPC1RAB9A
SCHEMBL29009667 0.61 HPGD (0.56) GABRA1GABRB2TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680606-A1 ADENINE DERIVATIVES AS HSP90 INHIBITORS AtmosR (FR) 2026-01-21 EP disclosed
WO-2024194175-A1 ADENINE DERIVATIVES AS HSP90 INHIBITORS ATMOSR (FR) 2024-09-26 WO disclosed